Form 8-K - Current report:
SEC Accession No. 0000950170-22-023218
Filing Date
2022-11-08
Accepted
2022-11-08 16:11:52
Documents
13
Period of Report
2022-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K asmb-20221108.htm   iXBRL 8-K 64422
2 EX-99.1 asmb-ex99_1.htm EX-99.1 354025
  Complete submission text file 0000950170-22-023218.txt   549173

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT asmb-20221108.xsd EX-101.SCH 2473
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT asmb-20221108_lab.xml EX-101.LAB 13373
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT asmb-20221108_pre.xml EX-101.PRE 10515
7 EXTRACTED XBRL INSTANCE DOCUMENT asmb-20221108_htm.xml XML 4546
Mailing Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35005 | Film No.: 221369015
SIC: 2834 Pharmaceutical Preparations